Bibliography
- NORMAN P: PDE4 inhibitors 2001 patent and literature activity 2000- September 2001. Expert Opin. Ther. Patents (2002) 12:93–112.
- •Recent review focussed on patent activity.
- VIGNOLA AM: PDE4 inhibitors in COPD - a more selective approach to treatment. Respir. Med. (2004) 98(0:495–503.
- •Focused on the most likely therapeutic indication of these agents.
- SPINA D: Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. Drugs (2003) 63(23):2575–2594.
- •Review from an alternative perspective.
- MONTANA JG, DYKE HJ: Update on the therapeutic potential of PDE4 inhibitors Expert Opin. Investig. Drugs (2002) 11:1–13.
- •Updated review of recent clinical developments.
- RENAU TE: The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges. Curr . Opin. Investig. Drugs (2004) 5(1):34–39.
- HATZELMANN A, SCHUDT C: Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J. Pharmacol. Exp. Ther. (2001) 297(1):267–279.
- BUNDUSCHUH DS, ELTZE M, BARSIG J et al.: In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J. Pharmacol. Exp. Ther. (2001) 297(1):280–290.